{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:01:18Z","timestamp":1785211278403,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"30","license":[{"start":{"date-parts":[[2011,11,14]],"date-time":"2011-11-14T00:00:00Z","timestamp":1321228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,11,14]],"date-time":"2011-11-14T00:00:00Z","timestamp":1321228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2012,7,26]]},"DOI":"10.1038\/onc.2011.520","type":"journal-article","created":{"date-parts":[[2011,11,14]],"date-time":"2011-11-14T11:39:36Z","timestamp":1321270776000},"page":"3525-3535","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Atypical mechanism of NF-\u03baB activation by TRE17\/ubiquitin-specific protease 6 (USP6) oncogene and its requirement in tumorigenesis"],"prefix":"10.1038","volume":"31","author":[{"given":"L M","family":"Pringle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Quick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D N","family":"Riquelme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A M","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M J","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M M","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,14]]},"reference":[{"key":"BFonc2011520_CR1","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1128\/MCB.15.5.2809","volume":"15","author":"JA Brockman","year":"1995","unstructured":"Brockman JA, Scherer DC, McKinsey TA, Hall SM, Qi X, Lee WY et al. (1995). Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation. Mol Cell Biol 15: 2809\u20132818.","journal-title":"Mol Cell Biol"},{"key":"BFonc2011520_CR2","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/nature01811","volume":"424","author":"TR Brummelkamp","year":"2003","unstructured":"Brummelkamp TR, Nijman SM, Dirac AM, Bernards R . (2003). Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. [comment]. Nature 424: 797\u2013801.","journal-title":"Nature"},{"key":"BFonc2011520_CR3","doi-asserted-by":"publisher","first-page":"55633","DOI":"10.1074\/jbc.M409825200","volume":"279","author":"H Buss","year":"2004","unstructured":"Buss H, Dorrie A, Schmitz ML, Hoffmann E, Resch K, Kracht M . (2004). Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription. J Biol Chem 279: 55633\u201355643.","journal-title":"J Biol Chem"},{"key":"BFonc2011520_CR4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2174\/092986707779941113","volume":"14","author":"MA Calzado","year":"2007","unstructured":"Calzado MA, Bacher S, Schmitz ML . (2007). NF-kappaB inhibitors for the treatment of inflammatory diseases and cancer. Curr Med Chem 14: 367\u2013376.","journal-title":"Curr Med Chem"},{"key":"BFonc2011520_CR5","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1210\/me.2006-0465","volume":"21","author":"S Choudhary","year":"2007","unstructured":"Choudhary S, Lu M, Cui R, Brasier AR . (2007). Involvement of a novel Rac\/RhoA guanosine triphosphatase-nuclear factor-kappaB inducing kinase signaling pathway mediating angiotensin II-induced RelA transactivation. Mol Endocrinol 21: 2203\u20132217.","journal-title":"Mol Endocrinol"},{"key":"BFonc2011520_CR6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00402-006-0223-5","volume":"127","author":"J Cottalorda","year":"2007","unstructured":"Cottalorda J, Bourelle S . (2007). Modern concepts of primary aneurysmal bone cyst. Arch Orthop Trauma Surg 127: 105\u2013114.","journal-title":"Arch Orthop Trauma Surg"},{"key":"BFonc2011520_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2174\/1568009054629645","volume":"5","author":"MA Dobrovolskaia","year":"2005","unstructured":"Dobrovolskaia MA, Kozlov SV . (2005). Inflammation and cancer: when NF-kappaB amalgamates the perilous partnership. Curr Cancer Drug Targets 5: 325\u2013344.","journal-title":"Curr Cancer Drug Targets"},{"key":"BFonc2011520_CR8","doi-asserted-by":"publisher","first-page":"13275","DOI":"10.1074\/jbc.M512815200","volume":"281","author":"A Douillette","year":"2006","unstructured":"Douillette A, Bibeau-Poirier A, Gravel SP, Clement JF, Chenard V, Moreau P et al. (2006). The proinflammatory actions of angiotensin II are dependent on p65 phosphorylation by the IkappaB kinase complex. J Biol Chem 281: 13275\u201313284.","journal-title":"J Biol Chem"},{"key":"BFonc2011520_CR9","doi-asserted-by":"publisher","first-page":"6680","DOI":"10.1038\/sj.onc.1209954","volume":"25","author":"TD Gilmore","year":"2006","unstructured":"Gilmore TD . (2006). Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 25: 6680\u20136684.","journal-title":"Oncogene"},{"key":"BFonc2011520_CR10","doi-asserted-by":"publisher","first-page":"re13","DOI":"10.1126\/stke.3572006re13","volume":"2006","author":"H Hacker","year":"2006","unstructured":"Hacker H, Karin M . (2006). Regulation and function of IKK and IKK-related kinases. Sci STKE 2006: re13.","journal-title":"Sci STKE"},{"key":"BFonc2011520_CR11","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1128\/JVI.01860-06","volume":"81","author":"MW Hansberger","year":"2007","unstructured":"Hansberger MW, Campbell JA, Danthi P, Arrate P, Pennington KN, Marcu KB et al. (2007). IkappaB kinase subunits alpha and gamma are required for activation of NF-kappaB and induction of apoptosis by mammalian reovirus. J Virol 81: 1360\u20131371.","journal-title":"J Virol"},{"key":"BFonc2011520_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/cr.2010.166","volume":"21","author":"EW Harhaj","year":"2011","unstructured":"Harhaj EW, Dixit VM . (2011). Deubiquitinases in the regulation of NF-kappaB signaling. Cell Res 21: 22\u201339.","journal-title":"Cell Res"},{"key":"BFonc2011520_CR13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1128\/MCB.26.2.457-471.2006","volume":"26","author":"JE Hoberg","year":"2006","unstructured":"Hoberg JE, Popko AE, Ramsey CS, Mayo MW . (2006). IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA\/p65 by p300. Mol Cell Biol 26: 457\u2013471.","journal-title":"Mol Cell Biol"},{"key":"BFonc2011520_CR14","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1093\/carcin\/bgh198","volume":"25","author":"J Hu","year":"2004","unstructured":"Hu J, Nakano H, Sakurai H, Colburn NH . (2004). Insufficient p65 phosphorylation at S536 specifically contributes to the lack of NF-kappaB activation and transformation in resistant JB6 cells. Carcinogenesis 25: 1991\u20132003.","journal-title":"Carcinogenesis"},{"key":"BFonc2011520_CR15","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature04870","volume":"441","author":"M Karin","year":"2006","unstructured":"Karin M . (2006). Nuclear factor-kappaB in cancer development and progression. Nature 441: 431\u2013436.","journal-title":"Nature"},{"key":"BFonc2011520_CR16","doi-asserted-by":"publisher","first-page":"6965","DOI":"10.4049\/jimmunol.173.11.6965","volume":"173","author":"NA Khandaker","year":"2004","unstructured":"Khandaker NA, Fazal F, Malik AB, Rahman A . (2004). RhoA\/Rho-associated kinase pathway selectively regulates thrombin-induced intercellular adhesion molecule-1. Expression in endothelial cells via activation of I\u03baB kinase \u03b2 and phosphorylation of RelA\/p65. J Immunol 173: 6965\u20136972.","journal-title":"J Immunol"},{"key":"BFonc2011520_CR17","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nature01802","volume":"424","author":"A Kovalenko","year":"2003","unstructured":"Kovalenko A, Chable-Bessia C, Cantarella G, Israel A, Wallach D, Courtois G . (2003). The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. [comment]. Nature 424: 801\u2013805.","journal-title":"Nature"},{"key":"BFonc2011520_CR18","doi-asserted-by":"publisher","first-page":"37111","DOI":"10.1074\/jbc.M110.175133","volume":"285","author":"AW Lau","year":"2010","unstructured":"Lau AW, Pringle LM, Quick L, Riquelme DN, Ye Y, Oliveira AM et al. (2010). TRE17\/Ubiquitin-specific protease 6 (USP6) oncogene translocated in aneurysmal bone cyst blocks osteoblastic maturation via an autocrine mechanism involving bone morphogenetic protein dysregulation. J Biol Chem 285: 37111\u201337120.","journal-title":"J Biol Chem"},{"key":"BFonc2011520_CR19","doi-asserted-by":"publisher","first-page":"5656","DOI":"10.1158\/1078-0432.CCR-08-0123","volume":"14","author":"DF Lee","year":"2008","unstructured":"Lee DF, Hung MC . (2008). Advances in targeting IKK and IKK-related kinases for cancer therapy. Clin Cancer Res 14: 5656\u20135662.","journal-title":"Clin Cancer Res"},{"key":"BFonc2011520_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/cr.2010.170","volume":"21","author":"S Liu","year":"2008","unstructured":"Liu S, Chen ZJ . (2008). Expanding role of ubiquitination in NF-kappaB signaling. Cell Res 21: 6\u201321.","journal-title":"Cell Res"},{"key":"BFonc2011520_CR21","doi-asserted-by":"publisher","first-page":"6756","DOI":"10.1200\/JCO.2005.15.255","volume":"23","author":"HJ Mankin","year":"2005","unstructured":"Mankin HJ, Hornicek FJ, Ortiz-Cruz E, Villafuerte J, Gebhardt MC . (2005). Aneurysmal bone cyst: a review of 150 patients. J Clin Oncol 23: 6756\u20136762.","journal-title":"J Clin Oncol"},{"key":"BFonc2011520_CR22","doi-asserted-by":"publisher","first-page":"9752","DOI":"10.1128\/MCB.24.22.9752-9762.2004","volume":"24","author":"L Martinu","year":"2004","unstructured":"Martinu L, Masuda-Robens JM, Robertson SE, Santy LC, Casanova JE, Chou MM . (2004). The TBC (Tre-2\/Bub2\/Cdc16) domain protein TRE17 regulates plasma membrane-endosomal trafficking through activation of Arf6. Mol Cell Biol 24: 9752\u20139762.","journal-title":"Mol Cell Biol"},{"key":"BFonc2011520_CR23","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1128\/MCB.23.6.2151-2161.2003","volume":"23","author":"JM Masuda-Robens","year":"2003","unstructured":"Masuda-Robens JM, Kutney SN, Qi H, Chou MM . (2003). The TRE17 oncogene encodes a component of a novel effector pathway for Rho GTPases Cdc42 and Rac 1 and stimulates actin remodeling. Mol Cell Biol 23: 2151\u20132161.","journal-title":"Mol Cell Biol"},{"key":"BFonc2011520_CR24","doi-asserted-by":"publisher","first-page":"6336","DOI":"10.4049\/jimmunol.172.10.6336","volume":"172","author":"I Mattioli","year":"2004","unstructured":"Mattioli I, Sebald A, Bucher C, Charles RP, Nakano H, Doi T et al. (2004). Transient and selective NF-kappa B p65 serine 536 phosphorylation induced by T cell costimulation is mediated by I kappa B kinase beta and controls the kinetics of p65 nuclear import. J Immunol 172: 6336\u20136344.","journal-title":"J Immunol"},{"key":"BFonc2011520_CR25","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/01.coc.0000204403.13451.52","volume":"29","author":"WM Mendenhall","year":"2006","unstructured":"Mendenhall WM, Zlotecki RA, Gibbs CP, Reith JD, Scarborough MT, Mendenhall NP . (2006). Aneurysmal bone cyst. Am J Clin Oncol 29: 311\u2013315.","journal-title":"Am J Clin Oncol"},{"key":"BFonc2011520_CR26","first-page":"733","volume":"7","author":"T Nakamura","year":"1992","unstructured":"Nakamura T, Hillova J, Mariage-Samson R, Onno M, Huebner K, Cannizzaro LA et al. (1992). A novel transcriptional unit of the tre oncogene widely expressed in human cancer cells. Oncogene 7: 733\u2013741.","journal-title":"Oncogene"},{"key":"BFonc2011520_CR27","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1158\/0008-5472.CAN-03-2827","volume":"64","author":"AM Oliveira","year":"2004","unstructured":"Oliveira AM, Hsi BL, Weremowicz S, Rosenberg AE, Dal Cin P, Joseph N et al. (2004a). USP6 (Tre2) fusion oncogenes in aneurysmal bone cyst. Cancer Res 64: 1920\u20131923.","journal-title":"Cancer Res"},{"key":"BFonc2011520_CR28","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1038\/sj.onc.1208506","volume":"24","author":"AM Oliveira","year":"2005","unstructured":"Oliveira AM, Perez-Atayde AR, Dal Cin P, Gebhardt MC, Chen CJ, Neff JR et al. (2005). Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes. Oncogene 24: 3419\u20133426.","journal-title":"Oncogene"},{"key":"BFonc2011520_CR29","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/S0002-9440(10)63432-3","volume":"165","author":"AM Oliveira","year":"2004","unstructured":"Oliveira AM, Perez-Atayde AR, Inwards CY, Medeiros F, Derr V, Hsi BL et al. (2004b). USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts. Am J Pathol 165: 1773\u20131780.","journal-title":"Am J Pathol"},{"key":"BFonc2011520_CR30","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1471-4914(02)02375-4","volume":"8","author":"RZ Orlowski","year":"2002","unstructured":"Orlowski RZ, Baldwin Jr AS . (2002). NF-kappaB as a therapeutic target in cancer. Trends Mol Med 8: 385\u2013389.","journal-title":"Trends Mol Med"},{"key":"BFonc2011520_CR31","doi-asserted-by":"publisher","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","volume":"18","author":"HL Pahl","year":"1999","unstructured":"Pahl HL . (1999). Activators and target genes of Rel\/NF-kappaB transcription factors. Oncogene 18: 6853\u20136866.","journal-title":"Oncogene"},{"key":"BFonc2011520_CR32","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.ejca.2006.01.002","volume":"42","author":"BJ Rollins","year":"2006","unstructured":"Rollins BJ . (2006). Inflammatory chemokines in cancer growth and progression. Eur J Cancer 42: 760\u2013767.","journal-title":"Eur J Cancer"},{"key":"BFonc2011520_CR33","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s00402-007-0477-6","volume":"128","author":"B Saccomanni","year":"2008","unstructured":"Saccomanni B . (2008). Aneurysmal bone cyst of spine: a review of literature. Arch Orthop Trauma Surg 128: 1145\u20131147.","journal-title":"Arch Orthop Trauma Surg"},{"key":"BFonc2011520_CR34","doi-asserted-by":"publisher","first-page":"30353","DOI":"10.1074\/jbc.274.43.30353","volume":"274","author":"H Sakurai","year":"1999","unstructured":"Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W . (1999). IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 274: 30353\u201330356.","journal-title":"J Biol Chem"},{"key":"BFonc2011520_CR35","doi-asserted-by":"publisher","first-page":"36916","DOI":"10.1074\/jbc.M301598200","volume":"278","author":"H Sakurai","year":"2003","unstructured":"Sakurai H, Suzuki S, Kawasaki N, Nakano H, Okazaki T, Chino A et al. (2003). Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway. J Biol Chem 278: 36916\u201336923.","journal-title":"J Biol Chem"},{"key":"BFonc2011520_CR36","doi-asserted-by":"publisher","first-page":"34538","DOI":"10.1074\/jbc.M504943200","volume":"280","author":"CY Sasaki","year":"2005","unstructured":"Sasaki CY, Barberi TJ, Ghosh P, Longo DL . (2005). Phosphorylation of RelA\/p65 on serine 536 defines an I{kappa}B{alpha}-independent NF-{kappa}B pathway. J Biol Chem 280: 34538\u201334547.","journal-title":"J Biol Chem"},{"key":"BFonc2011520_CR37","doi-asserted-by":"publisher","first-page":"35967","DOI":"10.1074\/jbc.M505220200","volume":"280","author":"C Shen","year":"2005","unstructured":"Shen C, Ye Y, Robertson SE, Lau AW, Mak DO, Chou MM . (2005). Calcium\/calmodulin regulates ubiquitination of the ubiquitin-specific protease TRE17\/USP6. J Biol Chem 280: 35967\u201335973.","journal-title":"J Biol Chem"},{"key":"BFonc2011520_CR38","doi-asserted-by":"publisher","first-page":"12536","DOI":"10.1074\/jbc.M109.099630","volume":"285","author":"H Shimada","year":"2010","unstructured":"Shimada H, Rajagopalan LE . (2010). Rho kinase-2 activation in human endothelial cells drives lysophosphatidic acid-mediated expression of cell adhesion molecules via NF-kappaB p65. J Biol Chem 285: 12536\u201312542.","journal-title":"J Biol Chem"},{"key":"BFonc2011520_CR39","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.1128\/MCB.00578-08","volume":"28","author":"R Sitcheran","year":"2008","unstructured":"Sitcheran R, Comb WC, Cogswell PC, Baldwin AS . (2008). Essential role for epidermal growth factor receptor in glutamate receptor signaling to NF-kappaB. Mol Cell Biol 28: 5061\u20135070.","journal-title":"Mol Cell Biol"},{"key":"BFonc2011520_CR40","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1074\/jbc.M110572200","volume":"277","author":"N Sizemore","year":"2002","unstructured":"Sizemore N, Lerner N, Dombrowski N, Sakurai H, Stark GR . (2002). Distinct roles of the Ikappa B kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-kappa B) from Ikappa B and in phosphorylating the p65 subunit of NF-kappa B. J Biol Chem 277: 3863\u20133869.","journal-title":"J Biol Chem"},{"key":"BFonc2011520_CR41","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1146\/annurev.biochem.78.070907.102750","volume":"78","author":"B Skaug","year":"2009","unstructured":"Skaug B, Jiang X, Chen ZJ . (2009). The role of ubiquitin in NF-kappaB regulatory pathways. Annu Rev Biochem 78: 769\u2013796.","journal-title":"Annu Rev Biochem"},{"key":"BFonc2011520_CR42","doi-asserted-by":"publisher","first-page":"8724","DOI":"10.1074\/jbc.M609613200","volume":"282","author":"LA Solt","year":"2007","unstructured":"Solt LA, Madge LA, Orange JS, May MJ . (2007). Interleukin-1-induced NF-kappaB activation is NEMO-dependent but does not require IKKbeta. J Biol Chem 282: 8724\u20138733.","journal-title":"J Biol Chem"},{"key":"BFonc2011520_CR43","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/j.cellsig.2009.05.007","volume":"21","author":"W Sun","year":"2009","unstructured":"Sun W, Li H, Yu Y, Fan Y, Grabiner BC, Mao R et al. (2009). MEKK3 is required for lysophosphatidic acid-induced NF-kappaB activation. Cell Signal 21: 1488\u20131494.","journal-title":"Cell Signal"},{"key":"BFonc2011520_CR44","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nature01803","volume":"424","author":"E Trompouki","year":"2003","unstructured":"Trompouki E, Hatzivassiliou E, Tsichritzis T, Farmer H, Ashworth A, Mosialos G . (2003). CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. [comment]. Nature 424: 793\u2013796.","journal-title":"Nature"},{"key":"BFonc2011520_CR45","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.tibs.2004.11.009","volume":"30","author":"P Viatour","year":"2005","unstructured":"Viatour P, Merville MP, Bours V, Chariot A . (2005). Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci 30: 43\u201352.","journal-title":"Trends Biochem Sci"},{"key":"BFonc2011520_CR46","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nature02794","volume":"430","author":"IE Wertz","year":"2004","unstructured":"Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S et al. (2004). De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430: 694\u2013699.","journal-title":"Nature"},{"key":"BFonc2011520_CR47","doi-asserted-by":"publisher","first-page":"5630","DOI":"10.4049\/jimmunol.170.11.5630","volume":"170","author":"F Yang","year":"2003","unstructured":"Yang F, Tang E, Guan K, Wang CY . (2003). IKK beta plays an essential role in the phosphorylation of RelA\/p65 on serine 536 induced by lipopolysaccharide. J Immunol 170: 5630\u20135635.","journal-title":"J Immunol"},{"key":"BFonc2011520_CR48","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1038\/onc.2010.116","volume":"29","author":"Y Ye","year":"2010","unstructured":"Ye Y, Pringle LM, Lau AW, Riquelme DN, Wang H, Jiang T et al. (2010). TRE17\/USP6 oncogene translocated in aneurysmal bone cyst induces matrix metalloproteinase production via activation of NF-kappaB. Oncogene 29: 3619\u20133629.","journal-title":"Oncogene"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2011520.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2011520","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2011520.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T18:44:02Z","timestamp":1647888242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2011520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,14]]},"references-count":48,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2012,7,26]]}},"alternative-id":["BFonc2011520"],"URL":"https:\/\/doi.org\/10.1038\/onc.2011.520","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,14]]},"assertion":[{"value":"23 May 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}